Literature DB >> 18675787

Alternative splicing generates a short BCL6 (BCL6S) isoform encoding a compact repressor.

Yulei Shen1, Baosheng Ge, Himabindu Ramachandrareddy, Timothy McKeithan, Wing C Chan.   

Abstract

BCL6 gene transcribes two main mRNA isoforms, variant 1 and variant 2, which have distinct transcription start sites. However, these two isoforms encode identical BCL6 protein. Recently, a third variant was sequenced from a human hippocampus cDNA library (DB465062). In this study, we cloned and sequenced a novel BCL6 spliced isoform (BCL6S) which lacks exon 7 that encodes the first two zinc fingers of BCL6. We found a splicing isoform, BCL6S, that excludes exon 7 but retains the last four of the six zinc fingers (ZFs) coding region of the BCL6 gene. BCL6S mRNA and protein were expressed in human cell lines and tissues that expressed BCL6, but accounted for a minor portion of BCL6 transcripts or protein. BCL6S protein was also detectable in BCL6 positive cells. BCL6S could form homodimers or heterodimers with BCL6 and could bind to classical BCL6-binding sites. Luciferase reporter assays demonstrated that BCL6S could effectively repress typical BCL6 target genes. BCL6S is a compact repressor that may have a functional role in normal and neoplastic germinal center B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675787      PMCID: PMC2573862          DOI: 10.1016/j.bbrc.2008.07.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor.

Authors:  Claudie Lemercier; Marie-Paule Brocard; Francine Puvion-Dutilleul; Hung-Ying Kao; Olivier Albagli; Saadi Khochbin
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

2.  Acetylation inactivates the transcriptional repressor BCL6.

Authors:  Oksana R Bereshchenko; Wei Gu; Riccardo Dalla-Favera
Journal:  Nat Genet       Date:  2002-10-28       Impact factor: 38.330

3.  MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.

Authors:  Naoyuki Fujita; David L Jaye; Cissy Geigerman; Adil Akyildiz; Myesha R Mooney; Jeremy M Boss; Paul A Wade
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

4.  BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.

Authors:  Ryan T Phan; Masumichi Saito; Katia Basso; Huifeng Niu; Riccardo Dalla-Favera
Journal:  Nat Immunol       Date:  2005-09-04       Impact factor: 25.606

5.  Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.

Authors:  P Dhordain; O Albagli; N Honore; F Guidez; D Lantoine; M Schmid; H D The; A Zelent; M H Koken
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

6.  Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.

Authors:  Chih-Hao Lee; Ajay Chawla; Ned Urbiztondo; Debbie Liao; William A Boisvert; Ronald M Evans; Linda K Curtiss
Journal:  Science       Date:  2003-09-11       Impact factor: 47.728

7.  Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.

Authors:  Heather M Bond; Maria Mesuraca; Ennio Carbone; Patrizia Bonelli; Valter Agosti; Nicola Amodio; Gennaro De Rosa; Massimo Di Nicola; Alessandro M Gianni; Malcolm A S Moore; Akiko Hata; Michele Grieco; Giovanni Morrone; Salvatore Venuta
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

8.  Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.

Authors:  Xavier Mascle; Olivier Albagli; Claudie Lemercier
Journal:  Biochem Biophys Res Commun       Date:  2003-01-10       Impact factor: 3.575

9.  Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.

Authors:  B W Baron; G Nucifora; N McCabe; R Espinosa; M M Le Beau; T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Antigenic and immunogenic properties of cyanogen bromide peptides from gonococcal outer membrane protein IB. Evidence for the existence of a surface-exposed conserved epitope.

Authors:  T Teerlink; H Versantvoort; E C Beuvery
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  2 in total

1.  Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.

Authors:  Xin Huang; Yulei Shen; Miao Liu; Chengfeng Bi; Chunsun Jiang; Javeed Iqbal; Timothy W McKeithan; Wing C Chan; Shi-Jian Ding; Kai Fu
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

2.  Alternative splicing of medaka bcl6aa and its repression by Prdm1a and Prdm1b.

Authors:  Xiaomei Ke; Runshuai Zhang; Qiting Yao; Shi Duan; Wentao Hong; Mengxi Cao; Qingchun Zhou; Xueping Zhong; Haobin Zhao
Journal:  Fish Physiol Biochem       Date:  2021-07-03       Impact factor: 2.794

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.